Related Experiment Video
Updated: Nov 25, 2025

07:59
Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
828
A highly sensitive method for the detection of recombinant PERV-A/C env RNA using next generation sequencing
Ken Kono1, Kiyoko Kataoka1, Yuzhe Yuan2
1Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki Ward, Kawasaki City, Kanagawa, 210-9501, Japan.
Scientific Reports
|December 15, 2020
Summary
This study developed a sensitive next-generation sequencing (NGS) method to detect porcine endogenous retrovirus (PERV)-A/C. This technique is crucial for monitoring PERV-A/C emergence after xenotransplantation of porcine products.
Area of Science:
- Xenotransplantation research
- Virology
- Biotechnology
Background:
- Xenogenic cell-based therapies, like porcine islet cells for diabetes, face PERV transmission risks.
- Four PERV subgroups exist (PERV-A, -B, -C, PERV-A/C), with PERV-A/C showing high prevalence and potential viremia increase in diseased pigs.
- Monitoring PERV-A/C emergence post-transplantation is critical for xenotransplantation safety.
Purpose of the Study:
- To develop a highly sensitive detection method for PERV-A/C.
- To assess the utility of next-generation sequencing (NGS) for PERV-A/C detection.
Main Methods:
- Developed a sensitive method using next-generation sequencing (NGS) technologies.
- Utilized RT-PCR to amplify PERV-C spiked with varying PERV-A/C doses.
- Analyzed amplicons via NGS.
Main Results:
- NGS successfully detected PERV-A/C at 1% abundance with 100% true positive rate.
- NGS also detected PERV-A/C at 0.1% abundance with a 57% true positive rate.
- The method demonstrates high sensitivity for PERV-A/C detection.
Conclusions:
- The developed NGS method is highly sensitive and effective for detecting PERV-A/C.
- This technique can be valuable for rapid monitoring of PERV-A/C emergence after xenotransplantation.
- Ensures the safety and efficacy of porcine-derived cell therapies.

